Format

Send to

Choose Destination
J Pediatr. 2014 Feb;164(2):416-8. doi: 10.1016/j.jpeds.2013.10.008. Epub 2013 Nov 16.

Self-reported treatment practices by healthcare providers could lead to death from Rocky Mountain spotted fever.

Author information

1
The Ohio State University, College of Veterinary Medicine, Columbus, OH.
2
Rickettsial Zoonoses Branch, Division of Vector-borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA.
3
Rickettsial Zoonoses Branch, Division of Vector-borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA. Electronic address: jregan@cdc.gov.

Abstract

Among 2012 Docstyle survey respondents, 80% identified doxycycline as the appropriate treatment for Rocky Mountain spotted fever in patients ≥ 8 years old, but only 35% correctly chose doxycycline in patients <8 years old. These findings raise concerns about the higher pediatric case-fatality rate of Rocky Mountain spotted fever observed nationally. Targeted education efforts are needed.

KEYWORDS:

CME; Continuing medical education; HCP; Healthcare provider; RMSF; Rocky Mountain spotted fever

PMID:
24252781
PMCID:
PMC4699435
DOI:
10.1016/j.jpeds.2013.10.008
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center